INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

11119	Companies
244817	Keywords
172888	Articles
132001	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 07/09/2025 at 22:05, 1 year 2 months ago

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
Inventiva appoints Jason Campagna as President of R&D and CMO and Martine Zimmermann as EVP of Regulatory Affairs and Quality Assurance, emphasizing long-term growth and operational excellence

Quality Assurance R&D Leadership Appointments Regulatory Affairs Inventiva
BRIEF

published on 07/07/2025 at 22:05, 1 year 2 months ago

Inventiva Receives $10 Million Milestone Payment from CTTQ

Milestone Payment Lanifibranor Biopharmaceutical Development MASH Treatment CTTQ Partnership
BRIEF

published on 07/07/2025 at 22:05, 1 year 2 months ago

Inventiva reçoit un paiement d'étape de 10 millions de dollars du CTTQ

Paiement D'étape Lanifibranor Développement Biopharmaceutique Traitement MASH Partenariat CTTQ
PRESS RELEASE

published on 07/07/2025 at 22:00, 1 year 2 months ago

Inventiva receives $10 million milestone payment from CTTQ
Inventiva receives $10 million milestone payment from CTTQ following successful structured financing. Partnership aims to develop lanifibranor for MASH treatment in Chinese regions

Inventiva Milestone Payment MASH Lanifibranor CTTQ
PRESS RELEASE

published on 07/07/2025 at 22:00, 1 year 2 months ago

Inventiva receives $10 million milestone payment from CTTQ
Inventiva reçoit un paiement d'étape de 10 millions de dollars de la part de CTTQ pour le développement de thérapies contre la stéatohépatite. Accord de licence avec potentiel de 265 millions de dollars supplémentaires

Paiement Inventiva Stéatohépatite Thérapies CTTQ
BRIEF

published on 07/02/2025 at 22:05, 1 year 3 months ago

Inventiva Publishes Promising Results on Lanifibranor for Liver Disease

Phase 2b Study Liver Disease Lanifibranor MASH Treatment Journal Of Hepatology Reports
BRIEF

published on 07/02/2025 at 22:05, 1 year 3 months ago

Inventiva publie des résultats prometteurs sur le lanifibranor pour les maladies du foie

Étude De Phase 2b Maladie Du Foie Lanifibranor Traitement MASH Journal Des Rapports D'hépatologie
PRESS RELEASE

published on 07/02/2025 at 22:00, 1 year 3 months ago

Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease
Inventiva announces publication in Journal of Hepatology Reports on lanifibranor treatment effects on liver sinusoidal endothelial cells in MASLD/MASH patients and preclinical models, showing potential therapeutic benefits

Inventiva MASH Lanifibranor Journal Of Hepatology Reports LSEC Capillarization
PRESS RELEASE

published on 07/02/2025 at 22:00, 1 year 3 months ago

Inventiva annonce la publication dans le Journal of Hepatology Reports des résultats du lanifibranor sur les cellules endothéliales sinusoïdales hépatiques chez des patients MASLD/MASH et dans des modèles précliniques de la maladie
Inventiva annonce la publication des résultats du lanifibranor sur les cellules endothéliales sinusoïdales hépatiques chez des patients MASLD/MASH. Des effets bénéfiques allant au-delà de l'inversion de la capillarisation ont été observés

Inventiva MASH MASLD Lanifibranor Cellules Endothéliales
BRIEF

published on 06/10/2025 at 22:05, 1 year 3 months ago

Renée Aguiar-Lucander Joins Inventiva's Board of Directors

Board Of Directors Biopharmaceutical Inventiva Lanifibranor Renée Aguiar-Lucander

Accesswire

Published on 10/03/2026 at 02:35, 1 day 15 hours ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 23 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 2 days 3 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 4 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 4 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/04/2026 at 06:05, 11 hours 34 minutes ago

Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 12 hours 24 minutes ago

SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 1 hour ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 17 hours ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 21 hours ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding

Les Echos

Published on 10/02/2026 at 17:45, 1 day 23 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 1 day 23 hours ago

Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 2 days ago

Aéroports de Paris SA - Calendrier financier 2027

View all LES ECHOS COMFI WIRE